Bessemer Group’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$162K Buy
13,508
+635
+5% +$7.49K ﹤0.01% 1392
2026
Q2
$138K Hold
12,873
– – ﹤0.01% 1457
2026
Q1
$82K Hold
12,873
– – ﹤0.01% 1547
2025
Q4
$91K Buy
12,873
+12,265
+2,017% +$74K ﹤0.01% 1501
2025
Q3
$3K Sell
608
-277
-31% -$1.36K ﹤0.01% 2243
2025
Q2
$5K Hold
885
– – ﹤0.01% 2028
2025
Q1
$6K Sell
885
-819
-48% -$6.23K ﹤0.01% 1958
2024
Q4
$13K Sell
1,704
-8,264
-83% -$59.3K ﹤0.01% 1656
2024
Q3
$70K Buy
9,968
+825
+9% +$4.96K ﹤0.01% 1331
2024
Q2
$45K Hold
9,143
– – ﹤0.01% 1297
2024
Q1
$56K Buy
9,143
+2,768
+43% +$18.6K ﹤0.01% 1281
2023
Q4
$50K Buy
6,375
+1,179
+23% +$7.6K ﹤0.01% 1338
2023
Q3
$36K Buy
+5,196
New +$42.1K ﹤0.01% 1384

Other funds holding LFST

Bessemer Group's LFST Position: Q3 2026 in Review

Bessemer Group increased its Lifestance Health (LFST) stake by 4.9% in Q3 2026, buying an estimated $7.49K and bringing the position to 13,508 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #1392.

Bessemer Group first reported a position in LFST in Q3 2023 and has held it in 13 quarters since. 324 funds tracked by Wall St. Rank hold LFST as of Q3 2026.

  • Bessemer Group held 13,508 shares of Lifestance Health worth $162K as of Q3 2026.
  • Bessemer Group bought 635 Lifestance Health shares in Q3 2026, an estimated $7.49K.
  • Lifestance Health made up ﹤0.01% of Bessemer Group's portfolio in Q3 2026, its #1392 holding.
  • Bessemer Group first reported a position in Lifestance Health in Q3 2023 and has held it in 13 quarters since.
  • 324 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2026.

Based on Bessemer Group's 13F filing for Q3 2026, filed 9 Nov 2026.